Trial Profile

A trial to determine changes of lymphocyte counts (CD4 and CD8 T cells, B cells and their subtypes) in the peripheral blood of patients with multiple sclerosis treated for an extended period with fingolimod (MSFin) compared to healthy controls (HC).

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 14 Sep 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

04 May 2016 New trial record
21 Apr 2016 Results presented at the 68th Annual Meeting of the American Academy of Neurology

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com